Literature DB >> 241805

Evidence for a clorgyline-resistant monoamine metabolizing activity in the rat heart.

G A Lyles, B A Callingham.   

Abstract

When benzylamine was used as substrate, a component of the total monoamine oxidase (MAO) activity in the rat heart was found to be resistant to inhibition by clorgyline. The proportion of the total activity represented by this component, decreased as the rat grew. It was also inhibited by both semicarbazide and isoniazid but not by potassium cyanide. Inhibitor studies with MAO in subcellular fractions showed that this component was more concentrated in the microsomal and soluble fractions. However, it could not be concluded that the activity was entirely a soluble enzyme. Determination of quasi-Michaelis constants ("Km") for total benzylamine oxidizing activity revealed a high ("Km" of approximately 10(-5)M) and low ("Km" of approximately 5 X 10(-4)M) affinity component. The high affinity component was inhibited by semicarbazide and the low affinity component by clorgyline. In the presence of 10(-3)M clorgyline, the high affinity component showed substrate inhibition at higher substrate concentrations. The possibility is discussed that the clorgyline-resistant activity is due to an amine-oxidizing activity distinct from mitochondrial MAO.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241805

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung.

Authors:  J M Lizcano; K F Tipton; M Unzeta
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

2.  The inhibition of human heart monoamine oxidase [proceedings].

Authors:  B A Callingham; D Parkinson
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

3.  Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.

Authors:  M Eriksson; C J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

4.  Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.

Authors:  Y Koide; K Kobayashi
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

5.  [14C]-beta-phenethylamine, its distribution after administration by various routes to cats, and the effects of monoamine oxidase inhibitors.

Authors:  G Garcha; P R Imrie; E Marley; D V Thomas
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.